CCM
KYTH

Cadian Capital Management’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Cadian Capital Management’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-75,000
Closed -$2.98M – 104
2014
Q1 		$2.98M Buy
+75,000
New +$3.36M 0.07% 77

Other funds holding KYTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Cadian Capital Management's KYTH Position: Q2 2014 in Review

Cadian Capital Management sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q2 2014, closing a stake of 75,000 shares — an estimated $2.98M sold.

Cadian Capital Management first reported a position in KYTH in Q1 2014 and held it in 1 quarter. The position peaked at $2.98M in Q1 2014. 104 funds tracked by Wall St. Rank hold KYTH as of Q2 2014.

  • Cadian Capital Management reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q2 2014 after selling out during the quarter.
  • Cadian Capital Management sold 75,000 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q2 2014, an estimated $2.98M.
  • Cadian Capital Management first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q1 2014 and held it in 1 quarter.
  • Cadian Capital Management's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $2.98M in Q1 2014.
  • 104 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q2 2014.

Based on Cadian Capital Management's 13F filing for Q2 2014, filed 13 Aug 2014.